Molecularly imprinted polymers have emerged as synthetic biorecognition platforms capable of selectively identifying target chemical and biological structures, yet their translation from academic laboratories to commercial biosensors remains constrained by manufacturing, integration, and regulatory bottlenecks. In a comprehensive review published in Discover Sensors, researchers led by Merve Asena Özbek, Erdoğan Özgür, Aykut Arif Topçu, and Adil Denizli analyzed the operational principles, surface integration methodologies, diagnostic applications, and market limitations of molecular imprinting technology. Synthetic receptors mimic biological lock-and-key mechanisms by arranging functional monomers around a template analyte, fixing the arrangement via crosslinking polymerization, and subsequently extracting the template to reveal complementary cavities tailored in size, shape, and chemical functionality. While natural bioreceptors such as antibodies, enzymes, and aptamers frequently suffer from thermal instability, environmental degradation, high production costs, and limited availability for specialized analytes, synthetic plastic counterparts offer durable alternatives that avoid animal sacrifice and remain robust across varying operational conditions.
The engineering of molecularly imprinted polymers relies on precise chemical coordination among functional monomers, crosslinking agents, initiators, and porogenic solvents to establish selective recognition environments. Functional monomers engage template structures through covalent, non-covalent, or semi-covalent interactions prior to polymerization, establishing binding sites that replicate the non-covalent interactions characteristic of natural antibody-antigen or enzyme-substrate complexes. Crosslinking agents stabilize the three-dimensional polymeric architecture, preserving cavity geometries against environmental fluctuations in pH and ambient temperature while minimizing non-specific surface adsorption. Furthermore, the selection of porogenic solvents dictates the internal pore morphology and governs monomer-template interaction strength during assembly. Researchers have employed diverse synthetic strategies, including bulk polymerization, emulsion polymerization, surface imprinting, epitope imprinting, and sol-gel synthesis, to fine-tune mechanical resilience, thermal endurance, and affinity. Commercial manufacturers such as Semorex, MIP Technologies, and AFFINISEP have successfully deployed these synthetic matrices in analytical chemistry, separation science, and solid-phase extraction sorbents, demonstrating their utility beyond fundamental proof-of-concept testing.
Deploying molecularly imprinted polymers within analytical biosensors requires integrating them with physical transducer systems that translate specific molecular recognition events into measurable optical, electrochemical, mass-sensitive, or thermal outputs. In mass-sensitive configurations such as quartz crystal microbalances, binding interactions induce detectable frequency shifts corresponding to minute mass alterations on the sensor surface. Optical transducers leverage surface plasmon resonance or surface-enhanced Raman spectroscopy, detecting subtle refractive index variations or amplifying localized electromagnetic fields via plasmonic nanomaterials when target molecules bind to complementary cavities. Electrochemical platforms monitor oxidation-reduction reactions or impedance shifts occurring at electrode interfaces, converting chemical binding into tangible current, potential, or resistance changes. The overall analytical performance of these devices—encompassing operational linearity, detection sensitivity, limit of detection, and specificity—depends directly on maintaining transducer compatibility while optimizing the polymer-transducer interface.
Integrating imprinted matrices onto transducer surfaces involves distinct deposition methodologies, each presenting operational trade-offs between processing simplicity, film homogeneity, and structural reproducibility. Mechanical deposition routes, including micro-contact imprinting, drop casting, dip coating, and screen printing, require minimal surface functionalization and have facilitated the construction of surface plasmon resonance and quartz crystal microbalance sensors for whole cells and proteins. However, irregular film thickness and inconsistent particle distribution remain substantial challenges, prompting researchers to investigate master stamps, roll-to-roll processing, biopolymer binders, and encapsulation polymers to improve layer adhesion. Screen printing combines micro- or nano-sized imprinted particles with conductive formulations like graphene ink to fabricate flexible, low-waste electrodes suitable for wearable electronics, though carbon paste components can inadvertently adsorb onto or occlude selective binding cavities, dampening overall sensor responsiveness.
Alternative deposition strategies utilize electrochemical, chemical, and vapor-phase polymerization mechanisms to immobilize imprinted films directly on conductive substrates. Electrochemical deposition entails electropolymerizing electroactive monomers, such as aniline or pyrrole, under controlled potential sweeps to generate uniform conductive polymer films, though the technique is constrained by the limited availability of electroactive precursors and the susceptibility of base substrates like copper or aluminum to surface oxidation. Electrospinning applies strong electrical fields to polymer solutions or melts to yield continuous nanofibrous meshes, integrating imprinted particles either prior to fiber extrusion or synthesizing them in situ during nanofiber generation, although particle aggregation can reduce specific surface area and degrade operational stability. Chemical deposition methods leverage ultraviolet or thermal activation alongside surface grafting protocols to assemble scalable thin films on modified substrates via molecular linkers, whereas initiated chemical vapor deposition introduces gaseous precursors into vacuum chambers to construct nanostructured imprinted films with reproducible dimensions, albeit at higher operational and equipment costs.
Experimental studies across environmental testing, food quality surveillance, and clinical pathology have validated the analytical capabilities of biomimetic sensors against challenging target analytes. In food safety, an optical surface plasmon resonance sensor fabricated using methacrylic acid functional monomers and ethylene glycol dimethacrylate crosslinkers via spin coating detected histamine in real samples across a wide pH range, achieving an analytical limit of detection of 25 micrograms per liter, well below safe fish consumption thresholds. For infectious disease diagnostics, localized surface plasmon resonance chips modified via micro-contact imprinting with 2-hydroxyethyl methacrylate, N-methacryloyl-(L)-histidine methyl ester, and silver nanoparticles selectively recognized Escherichia coli cells, demonstrating a detection limit of 0.57 colony-forming units per milliliter in aqueous solution and 104 colony-forming units per milliliter in simulated urine matrices across repeated operational cycles. Similarly, surface-grafted nano-imprinted beads integrated with gold nanoparticles detected the pharmaceutical pollutant diclofenac down to 1.2 nanograms per milliliter, maintaining binding stability and selectivity over a twelve-month storage evaluation verified by liquid chromatography-mass spectrometry.
Clinical evaluations further highlight the performance parity between synthetic receptor sensors and conventional bioassays in complex physiological samples. An electrochemical sensor synthesized by electropolymerizing phenol on an electrode surface selectively targeted cancer antigen 125, an established ovarian cancer biomarker, achieving a detection limit of 0.5 units per milliliter in spiked and clinical human blood serum while maintaining analytical stability across 20 cycles, matching commercial enzyme-linked immunosorbent assay kit performance. In endocrine diagnostics, an electrochemical sensor incorporating graphene oxide and electropolymerized o-phenylenediamine onto glassy carbon electrodes quantified testosterone at femtomolar concentrations, achieving a detection limit of 0.4 femtomolar in aqueous and serum matrices with stable performance after 30 days of storage at room temperature. These findings confirm that synthetic polymers can replicate the selectivity of natural antibodies while providing superior resistance against environmental denaturation.
The expansion of non-invasive health monitoring has accelerated the deployment of molecularly imprinted polymers within flexible, skin-interfaced wearable sensor platforms. Traditional wearable devices primarily rely on physical sensors to record cardiovascular metrics, or utilize natural enzyme receptors to detect metabolic targets such as glucose, lactate, and alcohol, but enzymatic systems suffer from short shelf lives, high fabrication costs, and poor biochemical stability in sweat. Molecularly imprinted wearable architectures circumvent these limitations by establishing durable, regenerable sensing interfaces for hormones and metabolites. For example, a flexible polyethylene terephthalate wearable patch functionalized with polypyrrole, Prussian blue nanoparticles, and gold nanoparticles enabled real-time, in-situ chronoamperometric tracking of sweat cortisol, streaming quantitative biometric data via Bluetooth to mobile monitoring applications with accuracy comparable to traditional enzyme-linked immunosorbent assays.
Wearable integration has also advanced toward breathable smart textiles capable of continuous biomarker measurement and repeated physical maintenance. Hu and colleagues engineered a regenerable electrochemical fabric sensor by electropolymerizing pyrrole onto conductive carbon nanotube yarns, integrating Prussian blue redox probes to measure sweat cortisol. The device incorporated a polyvinyl alcohol hydrogel sweat-wicking membrane and miniaturized wireless circuitry, achieving a limit of detection of 1 picomolar while discriminating against common physiological interferents such as glucose, lactate, urea, and uric acid. Crucially, the breathable fabric sensor endured more than 150 automated washing machine cycles without structural deformation or analytical signal loss, illustrating the superior mechanical durability and operational resilience offered by synthetic polymer receptors over delicate biological counterparts in continuous point-of-care settings.
Despite thousands of registered patents and compelling laboratory demonstrations, molecular imprinting technology remains overwhelmingly confined to academic environments due to persistent translational barriers. The synthesis of imprinted polymers involves complex formulations of monomers, crosslinkers, and templates that function effectively in controlled small-scale settings but present significant reproducibility challenges when scaled up industrially. Incomplete template removal frequently leads to residual template leakage during testing, while heterogeneous binding site distributions generate inconsistent receptor affinities that degrade sensor reproducibility. Moreover, the narrow library of commercially viable monomers restricts the chemical space available to target complex biological macromolecules like proteins, where natural structural dynamics and conformational complexities impede traditional bulk imprinting.
Bridging this translational gap requires comprehensive system-level innovations spanning computational modeling, automated synthesis, interface engineering, and regulatory alignment. Emerging machine learning frameworks and artificial intelligence tools enable researchers to computationally screen functional monomers, predict target-monomer interaction energies, and optimize crosslinker ratios, significantly curtailing empirical trial cycles and enhancing binding site homogeneity. Industrial manufacturing transitions, such as semi-automated solid-phase reactors and template recycling protocols pioneered by MIP Diagnostics, reduce template consumption and eliminate batch-to-batch variability, enabling commercial prototypes such as rapid lateral-flow antigen platforms for SARS-CoV-2. Ultimately, transitioning from academic proof-of-concept prototypes to market-ready point-of-care devices demands strict adherence to Good Manufacturing Practice guidelines, early clinical validation in authentic biological fluids, and standardized regulatory documentation, ensuring that synthetic bioreceptors can reliably meet escalating global demands for durable, accessible diagnostic platforms.
Subject of Research: Commercialization challenges and biosensing applications of molecularly imprinted polymers
Article Title: Commercialization potential of molecularly imprinted polymers in biosensing applications
Article References: Özbek, M. A., Özgür, E., Topçu, A. A., & Denizli, A. (2026). Commercialization potential of molecularly imprinted polymers in biosensing applications. Discover Sensors, 2(1), Article 25. https://doi.org/10.1007/s44397-026-00056-y
Image Credits: AI Generated
DOI: 10.1007/s44397-026-00056-y
Keywords: molecularly imprinted polymers, biosensors, biomimetic sensors, surface plasmon resonance, electrochemical sensing, wearable biosensors, cortisol monitoring, micro-contact imprinting, electropolymerization, solid-phase synthesis, nanomaterials, chemical vapor deposition, good manufacturing practice, point-of-care diagnostics, cancer biomarkers, food safety analysis
News Source: Denise Maddox. (November 13, 2026). Molecularly Imprinted Polymers Face Commercial Biosensing Bottlenecks Despite Technical Advances. Scienmag.



